> top > docs > PMC:2889865 > spans > 14059-14567 > annotations

PMC:2889865 / 14059-14567 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T16538 10-21 NN denotes Involvement
T16539 22-24 IN denotes of
T16540 25-28 NN denotes PKC
T16541 29-32 CC denotes and
T16542 33-36 NN denotes JNK
T16543 37-39 IN denotes in
T16544 40-48 NN denotes cytokine
T16545 49-59 NN denotes expression
T16546 61-67 NN denotes Jurkat
T16547 68-75 NN denotes T-cells
T16548 76-80 VB denotes were
T16549 81-90 VB denotes incubated
T16550 91-95 IN denotes with
T16551 96-100 NN denotes PKC-
T16552 101-104 CC denotes and
T16553 105-108 NN denotes JNK
T16554 109-119 NN denotes inhibitors
T16555 120-123 IN denotes for
T16556 124-125 CD denotes 1
T16557 126-127 NN denotes h
T16558 128-136 VB denotes followed
T16559 137-139 IN denotes by
T16560 140-151 NN denotes stimulation
T16561 152-156 IN denotes with
T16562 157-160 NN denotes PMA
T16563 161-162 -LRB- denotes (
T16564 162-165 CD denotes 162
T16565 166-168 NN denotes nM
T16566 168-169 -RRB- denotes )
T16567 170-173 IN denotes for
T16568 174-176 CD denotes 24
T16569 177-179 NN denotes h.
T16570 180-181 -LRB- denotes (
T16571 181-182 NN denotes A
T16572 182-183 -RRB- denotes )
T16573 184-189 NN denotes CXCL8
T16574 190-200 NN denotes expression
T16575 201-204 VB denotes was
T16576 205-214 VB denotes inhibited
T16577 215-217 IN denotes in
T16578 218-219 DT denotes a
T16579 220-234 JJ denotes dose-dependent
T16580 235-241 NN denotes manner
T16581 242-244 IN denotes by
T16582 245-249 CC denotes both
T16583 250-261 NN denotes inhibitors.
T16584 262-263 -LRB- denotes (
T16585 263-264 NN denotes B
T16586 264-265 -RRB- denotes )
T16587 266-271 NN denotes JNK-I
T16588 272-280 VB denotes revealed
T16589 281-282 DT denotes a
T16590 283-291 JJ denotes stronger
T16591 292-302 JJ denotes inhibitory
T16592 303-309 NN denotes effect
T16593 310-312 IN denotes on
T16594 313-317 NN denotes IL-6
T16595 318-328 NN denotes expression
T16596 329-333 IN denotes than
T16597 334-337 DT denotes the
T16598 338-344 NN denotes PKC-I.
T16599 345-346 -LRB- denotes (
T16600 346-347 NN denotes C
T16601 347-348 -RRB- denotes )
T16602 349-352 NN denotes TNF
T16603 353-363 NN denotes expression
T16604 364-367 VB denotes was
T16605 368-371 RB denotes not
T16606 372-380 VB denotes affected
T16607 381-383 IN denotes by
T16608 384-390 DT denotes either
T16609 391-400 NN denotes inhibitor
T16610 402-413 JJ denotes Statistical
T16611 414-426 NN denotes significance
T16612 427-431 IN denotes from
T16613 432-435 DT denotes the
T16614 436-444 JJ denotes positive
T16615 445-452 NN denotes control
T16616 453-454 -LRB- denotes (
T16617 454-457 NN denotes PMA
T16618 457-458 -RRB- denotes )
T16619 459-462 VB denotes was
T16620 463-473 VB denotes determined
T16621 474-479 VB denotes using
T16622 480-487 NN denotes Student
T16623 487-489 POS denotes 's
T16624 490-497 NN denotes t-test.
T16625 498-499 -LRB- denotes (
T16626 499-500 NN denotes n
T16627 501-502 SYM denotes =
T16628 503-504 CD denotes 3
T16629 504-505 -RRB- denotes )
R13464 T16538 T16539 arg1Of Involvement,of
R13465 T16538 T16543 arg1Of Involvement,in
R13466 T16540 T16541 arg1Of PKC,and
R13467 T16541 T16539 arg2Of and,of
R13468 T16542 T16541 arg2Of JNK,and
R13469 T16545 T16543 arg2Of expression,in
R13470 T16545 T16544 arg1Of expression,cytokine
R13471 T16547 T16546 arg1Of T-cells,Jurkat
R13472 T16547 T16548 arg1Of T-cells,were
R13473 T16547 T16549 arg2Of T-cells,incubated
R13474 T16549 T16548 arg2Of incubated,were
R13475 T16549 T16550 arg1Of incubated,with
R13476 T16549 T16558 modOf incubated,followed
R13477 T16551 T16552 arg1Of PKC-,and
R13478 T16553 T16552 arg2Of JNK,and
R13479 T16554 T16550 arg2Of inhibitors,with
R13480 T16554 T16551 arg1Of inhibitors,PKC-
R13481 T16554 T16553 arg1Of inhibitors,JNK
R13482 T16554 T16555 arg1Of inhibitors,for
R13483 T16557 T16555 arg2Of h,for
R13484 T16557 T16556 arg1Of h,1
R13485 T16558 T16567 arg1Of followed,for
R13486 T16560 T16558 arg1Of stimulation,followed
R13487 T16560 T16559 arg2Of stimulation,by
R13488 T16560 T16561 arg1Of stimulation,with
R13489 T16562 T16561 arg2Of PMA,with
R13490 T16562 T16563 arg1Of PMA,(
R13491 T16565 T16563 arg2Of nM,(
R13492 T16565 T16564 arg1Of nM,162
R13493 T16566 T16563 arg3Of ),(
R13494 T16569 T16567 arg2Of h.,for
R13495 T16569 T16568 arg1Of h.,24
R13496 T16569 T16570 arg1Of h.,(
R13497 T16571 T16570 arg2Of A,(
R13498 T16572 T16570 arg3Of ),(
R13499 T16574 T16573 arg1Of expression,CXCL8
R13500 T16574 T16575 arg1Of expression,was
R13501 T16574 T16576 arg2Of expression,inhibited
R13502 T16576 T16575 arg2Of inhibited,was
R13503 T16576 T16577 arg1Of inhibited,in
R13504 T16580 T16577 arg2Of manner,in
R13505 T16580 T16578 arg1Of manner,a
R13506 T16580 T16579 arg1Of manner,dose-dependent
R13507 T16583 T16576 arg1Of inhibitors.,inhibited
R13508 T16583 T16581 arg2Of inhibitors.,by
R13509 T16583 T16582 arg1Of inhibitors.,both
R13510 T16583 T16584 arg1Of inhibitors.,(
R13511 T16585 T16584 arg2Of B,(
R13512 T16586 T16584 arg3Of ),(
R13513 T16587 T16588 arg1Of JNK-I,revealed
R13514 T16588 T16548 modOf revealed,were
R13515 T16588 T16575 modOf revealed,was
R13516 T16592 T16588 arg2Of effect,revealed
R13517 T16592 T16589 arg1Of effect,a
R13518 T16592 T16590 arg1Of effect,stronger
R13519 T16592 T16591 arg1Of effect,inhibitory
R13520 T16592 T16593 arg1Of effect,on
R13521 T16592 T16596 arg1Of effect,than
R13522 T16595 T16593 arg2Of expression,on
R13523 T16595 T16594 arg1Of expression,IL-6
R13524 T16600 T16599 arg2Of C,(
R13525 T16601 T16599 arg3Of ),(
R13526 T16603 T16597 arg1Of expression,the
R13527 T16603 T16598 arg1Of expression,PKC-I.
R13528 T16603 T16599 arg1Of expression,(
R13529 T16603 T16602 arg1Of expression,TNF
R13530 T16603 T16604 arg1Of expression,was
R13531 T16603 T16606 arg2Of expression,affected
R13532 T16606 T16596 arg2Of affected,than
R13533 T16606 T16604 arg2Of affected,was
R13534 T16606 T16605 arg1Of affected,not
R13535 T16609 T16606 arg1Of inhibitor,affected
R13536 T16609 T16607 arg2Of inhibitor,by
R13537 T16609 T16608 arg1Of inhibitor,either
R13538 T16611 T16610 arg1Of significance,Statistical
R13539 T16611 T16612 arg1Of significance,from
R13540 T16611 T16619 arg1Of significance,was
R13541 T16611 T16620 arg2Of significance,determined
R13542 T16615 T16612 arg2Of control,from
R13543 T16615 T16613 arg1Of control,the
R13544 T16615 T16614 arg1Of control,positive
R13545 T16615 T16616 arg1Of control,(
R13546 T16617 T16616 arg2Of PMA,(
R13547 T16618 T16616 arg3Of ),(
R13548 T16620 T16619 arg2Of determined,was
R13549 T16621 T16620 arg3Of using,determined
R13550 T16622 T16623 arg2Of Student,'s
R13551 T16624 T16621 arg2Of t-test.,using
R13552 T16624 T16623 arg1Of t-test.,'s
R13553 T16624 T16625 arg1Of t-test.,(
R13554 T16626 T16625 arg2Of n,(
R13555 T16626 T16627 arg1Of n,=
R13556 T16626 T16628 arg1Of n,3
R13557 T16629 T16625 arg3Of ),(

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T16439 10-21 NN denotes Involvement
T16440 22-24 IN denotes of
T16441 25-28 NNP denotes PKC
T16442 29-32 CC denotes and
T16443 33-36 NNP denotes JNK
T16444 37-39 IN denotes in
T16445 40-48 NN denotes cytokine
T16446 49-59 NN denotes expression
T16447 59-60 . denotes .
T16448 61-67 NNP denotes Jurkat
T16449 68-75 NNS denotes T-cells
T16450 76-80 VBD denotes were
T16451 81-90 VBN denotes incubated
T16452 91-95 IN denotes with
T16453 96-99 NNP denotes PKC
T16454 99-100 : denotes -
T16455 101-104 CC denotes and
T16456 105-108 NNP denotes JNK
T16457 109-119 NNS denotes inhibitors
T16458 120-123 IN denotes for
T16459 124-125 CD denotes 1
T16460 126-127 NN denotes h
T16461 128-136 VBN denotes followed
T16462 137-139 IN denotes by
T16463 140-151 NN denotes stimulation
T16464 152-156 IN denotes with
T16465 157-160 NNP denotes PMA
T16466 161-162 -LRB- denotes (
T16467 162-165 CD denotes 162
T16468 166-168 NNP denotes nM
T16469 168-169 -RRB- denotes )
T16470 170-173 IN denotes for
T16471 174-176 CD denotes 24
T16472 177-179 NN denotes h.
T16473 180-181 -LRB- denotes (
T16474 181-182 NNP denotes A
T16475 182-183 -RRB- denotes )
T16476 184-189 NNP denotes CXCL8
T16477 190-200 NN denotes expression
T16478 201-204 VBD denotes was
T16479 205-214 VBN denotes inhibited
T16480 215-217 IN denotes in
T16481 218-219 DT denotes a
T16482 220-234 JJ denotes dose-dependent
T16483 235-241 NN denotes manner
T16484 242-244 IN denotes by
T16485 245-249 DT denotes both
T16486 250-260 NNS denotes inhibitors
T16487 260-261 . denotes .
T16488 262-263 -LRB- denotes (
T16489 263-264 NNP denotes B
T16490 264-265 -RRB- denotes )
T16491 266-271 NNP denotes JNK-I
T16492 272-280 VBD denotes revealed
T16493 281-282 DT denotes a
T16494 283-291 JJR denotes stronger
T16495 292-302 JJ denotes inhibitory
T16496 303-309 NN denotes effect
T16497 310-312 IN denotes on
T16498 313-317 NN denotes IL-6
T16499 318-328 NN denotes expression
T16500 329-333 IN denotes than
T16501 334-337 DT denotes the
T16502 338-343 NNP denotes PKC-I
T16503 343-344 . denotes .
T16504 345-346 -LRB- denotes (
T16505 346-347 NNP denotes C
T16506 347-348 -RRB- denotes )
T16507 349-352 NNP denotes TNF
T16508 353-363 NN denotes expression
T16509 364-367 VBD denotes was
T16510 368-371 RB denotes not
T16511 372-380 VBN denotes affected
T16512 381-383 IN denotes by
T16513 384-390 DT denotes either
T16514 391-400 NN denotes inhibitor
T16515 400-401 . denotes .
T16516 402-413 NNP denotes Statistical
T16517 414-426 NN denotes significance
T16518 427-431 IN denotes from
T16519 432-435 DT denotes the
T16520 436-444 JJ denotes positive
T16521 445-452 NN denotes control
T16522 453-454 -LRB- denotes (
T16523 454-457 NNP denotes PMA
T16524 457-458 -RRB- denotes )
T16525 459-462 VBD denotes was
T16526 463-473 VBN denotes determined
T16527 474-479 VBG denotes using
T16528 480-487 NN denotes Student
T16529 487-489 POS denotes 's
T16530 490-496 JJS denotes t-test
T16531 496-497 . denotes .
T16532 498-499 -LRB- denotes (
T16533 499-500 FW denotes n
T16534 501-502 SYM denotes =
T16535 503-504 LS denotes 3
T16536 504-505 -RRB- denotes )
T16537 505-506 . denotes .
R13365 T16439 T16439 ROOT Involvement,Involvement
R13366 T16440 T16439 prep of,Involvement
R13367 T16441 T16440 pobj PKC,of
R13368 T16442 T16441 cc and,PKC
R13369 T16443 T16441 conj JNK,PKC
R13370 T16444 T16439 prep in,Involvement
R13371 T16445 T16446 amod cytokine,expression
R13372 T16446 T16444 pobj expression,in
R13373 T16447 T16439 punct .,Involvement
R13374 T16448 T16449 compound Jurkat,T-cells
R13375 T16449 T16451 nsubjpass T-cells,incubated
R13376 T16450 T16451 auxpass were,incubated
R13377 T16451 T16451 ROOT incubated,incubated
R13378 T16452 T16451 prep with,incubated
R13379 T16453 T16452 pobj PKC,with
R13380 T16454 T16451 punct -,incubated
R13381 T16455 T16451 cc and,incubated
R13382 T16456 T16457 compound JNK,inhibitors
R13383 T16457 T16479 nsubjpass inhibitors,inhibited
R13384 T16458 T16457 prep for,inhibitors
R13385 T16459 T16460 nummod 1,h
R13386 T16460 T16458 pobj h,for
R13387 T16461 T16457 acl followed,inhibitors
R13388 T16462 T16461 agent by,followed
R13389 T16463 T16462 pobj stimulation,by
R13390 T16464 T16461 prep with,followed
R13391 T16465 T16464 pobj PMA,with
R13392 T16466 T16465 punct (,PMA
R13393 T16467 T16468 nummod 162,nM
R13394 T16468 T16465 appos nM,PMA
R13395 T16469 T16465 punct ),PMA
R13396 T16470 T16461 prep for,followed
R13397 T16471 T16472 nummod 24,h.
R13398 T16472 T16470 pobj h.,for
R13399 T16473 T16474 punct (,A
R13400 T16474 T16477 nmod A,expression
R13401 T16475 T16474 punct ),A
R13402 T16476 T16477 compound CXCL8,expression
R13403 T16477 T16479 nsubjpass expression,inhibited
R13404 T16478 T16479 auxpass was,inhibited
R13405 T16479 T16451 conj inhibited,incubated
R13406 T16480 T16479 prep in,inhibited
R13407 T16481 T16483 det a,manner
R13408 T16482 T16483 amod dose-dependent,manner
R13409 T16483 T16480 pobj manner,in
R13410 T16484 T16479 agent by,inhibited
R13411 T16485 T16486 det both,inhibitors
R13412 T16486 T16484 pobj inhibitors,by
R13413 T16487 T16479 punct .,inhibited
R13414 T16488 T16491 punct (,JNK-I
R13415 T16489 T16491 nmod B,JNK-I
R13416 T16490 T16491 punct ),JNK-I
R13417 T16491 T16492 nsubj JNK-I,revealed
R13418 T16492 T16492 ROOT revealed,revealed
R13419 T16493 T16496 det a,effect
R13420 T16494 T16496 amod stronger,effect
R13421 T16495 T16496 compound inhibitory,effect
R13422 T16496 T16492 dobj effect,revealed
R13423 T16497 T16496 prep on,effect
R13424 T16498 T16499 amod IL-6,expression
R13425 T16499 T16497 pobj expression,on
R13426 T16500 T16499 prep than,expression
R13427 T16501 T16502 det the,PKC-I
R13428 T16502 T16500 pobj PKC-I,than
R13429 T16503 T16492 punct .,revealed
R13430 T16504 T16511 punct (,affected
R13431 T16505 T16508 nmod C,expression
R13432 T16506 T16505 punct ),C
R13433 T16507 T16508 compound TNF,expression
R13434 T16508 T16511 nsubjpass expression,affected
R13435 T16509 T16511 auxpass was,affected
R13436 T16510 T16511 neg not,affected
R13437 T16511 T16511 ROOT affected,affected
R13438 T16512 T16511 agent by,affected
R13439 T16513 T16514 det either,inhibitor
R13440 T16514 T16512 pobj inhibitor,by
R13441 T16515 T16511 punct .,affected
R13442 T16516 T16517 compound Statistical,significance
R13443 T16517 T16526 nsubjpass significance,determined
R13444 T16518 T16517 prep from,significance
R13445 T16519 T16521 det the,control
R13446 T16520 T16521 amod positive,control
R13447 T16521 T16518 pobj control,from
R13448 T16522 T16521 punct (,control
R13449 T16523 T16521 appos PMA,control
R13450 T16524 T16521 punct ),control
R13451 T16525 T16526 auxpass was,determined
R13452 T16526 T16526 ROOT determined,determined
R13453 T16527 T16526 advcl using,determined
R13454 T16528 T16530 poss Student,t-test
R13455 T16529 T16528 case 's,Student
R13456 T16530 T16527 dobj t-test,using
R13457 T16531 T16526 punct .,determined
R13458 T16532 T16535 punct (,3
R13459 T16533 T16534 advmod n,=
R13460 T16534 T16535 punct =,3
R13461 T16535 T16535 ROOT 3,3
R13462 T16536 T16535 punct ),3
R13463 T16537 T16535 punct .,3

GO-BP

Id Subject Object Predicate Lexical cue
T16636 25-28 http://purl.obolibrary.org/obo/GO_0004697 denotes PKC
T16637 96-99 http://purl.obolibrary.org/obo/GO_0004697 denotes PKC
T16638 338-341 http://purl.obolibrary.org/obo/GO_0004697 denotes PKC
T16639 33-36 http://purl.obolibrary.org/obo/GO_0004705 denotes JNK
T16640 105-108 http://purl.obolibrary.org/obo/GO_0004705 denotes JNK
T16641 266-269 http://purl.obolibrary.org/obo/GO_0004705 denotes JNK

GO-MF

Id Subject Object Predicate Lexical cue
T16642 25-28 http://purl.obolibrary.org/obo/GO_0004697 denotes PKC
T16643 96-99 http://purl.obolibrary.org/obo/GO_0004697 denotes PKC
T16644 338-341 http://purl.obolibrary.org/obo/GO_0004697 denotes PKC
T16645 33-36 http://purl.obolibrary.org/obo/GO_0004705 denotes JNK
T16646 105-108 http://purl.obolibrary.org/obo/GO_0004705 denotes JNK
T16647 266-269 http://purl.obolibrary.org/obo/GO_0004705 denotes JNK
T16648 313-317 http://purl.obolibrary.org/obo/GO_0005138 denotes IL-6

GO-CC

Id Subject Object Predicate Lexical cue
T16649 70-75 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T16436 10-60 Sentence denotes Involvement of PKC and JNK in cytokine expression.
T16437 61-401 Sentence denotes Jurkat T-cells were incubated with PKC- and JNK inhibitors for 1 h followed by stimulation with PMA (162 nM) for 24 h. (A) CXCL8 expression was inhibited in a dose-dependent manner by both inhibitors. (B) JNK-I revealed a stronger inhibitory effect on IL-6 expression than the PKC-I. (C) TNF expression was not affected by either inhibitor.
T16438 402-506 Sentence denotes Statistical significance from the positive control (PMA) was determined using Student's t-test. (n = 3).
T103 0-60 Sentence denotes Figure 6 Involvement of PKC and JNK in cytokine expression.
T104 61-401 Sentence denotes Jurkat T-cells were incubated with PKC- and JNK inhibitors for 1 h followed by stimulation with PMA (162 nM) for 24 h. (A) CXCL8 expression was inhibited in a dose-dependent manner by both inhibitors. (B) JNK-I revealed a stronger inhibitory effect on IL-6 expression than the PKC-I. (C) TNF expression was not affected by either inhibitor.
T105 402-506 Sentence denotes Statistical significance from the positive control (PMA) was determined using Student's t-test. (n = 3).

events-check-again

Id Subject Object Predicate Lexical cue
T16687 184-189 Protein denotes CXCL8
T16688 190-200 Gene_expression denotes expression
T16689 205-214 Negative_regulation denotes inhibited
T16690 225-234 Regulation denotes dependent
T16691 292-309 Negative_regulation denotes inhibitory effect
T16692 313-317 Protein denotes IL-6
T16693 318-328 Gene_expression denotes expression
R13584 T16687 T16688 themeOf CXCL8,expression
R13585 T16688 T16689 themeOf expression,inhibited
R13586 T16689 T16690 themeOf inhibited,dependent
R13587 T16692 T16693 themeOf IL-6,expression
R13588 T16693 T16691 themeOf expression,inhibitory effect

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T16694 25-28 Protein denotes PKC
T16695 33-36 Protein denotes JNK
T16696 96-99 Protein denotes PKC
T16697 105-108 Protein denotes JNK
T16698 109-119 Negative_regulation denotes inhibitors
T16699 109-119 Negative_regulation denotes inhibitors
T16700 184-189 Protein denotes CXCL8
T16701 190-200 Gene_expression denotes expression
T16702 205-214 Negative_regulation denotes inhibited
T16703 266-271 Protein denotes JNK-I
T16704 313-317 Protein denotes IL-6
T16705 338-343 Protein denotes PKC-I
T16706 318-328 Gene_expression denotes expression
T16707 349-352 Protein denotes TNF
T16708 353-363 Gene_expression denotes expression
T16709 372-380 Regulation denotes affected
R13589 T16696 T16698 themeOf PKC,inhibitors
R13590 T16697 T16699 themeOf JNK,inhibitors
R13591 T16700 T16701 themeOf CXCL8,expression
R13592 T16701 T16702 themeOf expression,inhibited
R13593 T16704 T16706 themeOf IL-6,expression
R13594 T16707 T16708 themeOf TNF,expression
R13595 T16708 T16709 themeOf expression,affected

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T16429 184-189 Protein denotes CXCL8
T16430 190-200 Gene_expression denotes expression
T16431 205-214 Negative_regulation denotes inhibited
T16432 225-234 Regulation denotes dependent
T16433 292-309 Negative_regulation denotes inhibitory effect
T16434 313-317 Protein denotes IL-6
T16435 318-328 Gene_expression denotes expression
R13360 T16429 T16430 themeOf CXCL8,expression
R13361 T16430 T16431 themeOf expression,inhibited
R13362 T16431 T16432 themeOf inhibited,dependent
R13363 T16434 T16435 themeOf IL-6,expression
R13364 T16435 T16433 themeOf expression,inhibitory effect

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T16630 184-189 P10145 denotes CXCL8
T16631 313-317 P05231 denotes IL-6
T16632 349-352 P01375 denotes TNF

test2

Id Subject Object Predicate Lexical cue
T16419 184-189 Protein denotes CXCL8
T16420 190-200 Gene_expression denotes expression
T16421 205-214 Negative_regulation denotes inhibited
T16422 225-234 Regulation denotes dependent
T16423 292-302 Negative_regulation denotes inhibitory
T16424 303-309 Regulation denotes effect
T16425 313-317 Protein denotes IL-6
T16426 318-328 Gene_expression denotes expression
T16427 353-363 Gene_expression denotes expression
T16428 372-380 Regulation denotes affected
R13354 T16419 T16420 themeOf CXCL8,expression
R13355 T16420 T16421 themeOf expression,inhibited
R13356 T16421 T16422 themeOf inhibited,dependent
R13357 T16425 T16426 themeOf IL-6,expression
R13358 T16426 T16424 themeOf expression,effect
R13359 T16427 T16428 themeOf expression,affected